|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:follitropin_alfa
|
|
gptkbp:approvalYear
|
2013
|
|
gptkbp:approvedBy
|
gptkb:European_Union
|
|
gptkbp:ATCCode
|
gptkb:G03GA05
|
|
gptkbp:biosimilar
|
gptkb:Gonal-f
|
|
gptkbp:contraindication
|
pregnancy
breastfeeding
primary ovarian failure
ovarian enlargement
uncontrolled thyroid or adrenal dysfunction
tumors of the hypothalamus or pituitary gland
|
|
gptkbp:form
|
solution for injection
|
|
gptkbp:hasTherapeuticUse
|
fertility treatment
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ovaleap
|
|
gptkbp:indication
|
assisted reproductive technology
controlled ovarian stimulation
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketingAuthorizationHolder
|
gptkb:Theramex_Ireland_Limited
|
|
gptkbp:mechanismOfAction
|
stimulates ovarian follicle development
|
|
gptkbp:pharmaceuticalCompany
|
gptkb:Theramex
|
|
gptkbp:pregnancyCategory
|
contraindicated
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
|
|
gptkbp:sideEffect
|
abdominal pain
headache
injection site reaction
ovarian hyperstimulation syndrome
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:bfsParent
|
gptkb:MRK
|
|
gptkbp:bfsLayer
|
5
|